Governance Quanterix Corporation

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
4.720 ^USD	-0.84%		-6.72%	-25.79%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Executive Committee: Quanterix Corporation

Manager

Positions heldSince

Everett Cunningham

59 year

Chief Executive Officer	2026-01-18
President	2026-01-18

Daniel Char

65 year

General Counsel

2025-11-30

Erica Bell

53 year

Human Resources Officer

2021-12-31

Vandana Sriram

52 year

Director of Finance/CFO	2023-08-20
Treasurer	2023-08-20

Michael F. Miller

Chief Operating Officer

2024-05-20

Brian P. Keane

General Counsel

Joshua S. Young

Investor Relations Contact

2024-11-30

Mark Roskey

66 year

Chief Tech/Sci/R&D Officer

Alexandra Phillips

Chief Tech/Sci/R&D Officer

2021-12-31

Composition of the Board of Directors: Quanterix Corporation

Director

CommitteesSince

William Donnelly

63 year

Audit Committee	2023-10-31
Governance Committee Chair	2017-04-30
Nominating Committee Chair	2017-04-30
Compensation Committee	2023-10-31

Karen Flynn

62 year

Governance Committee	2024-05-21
Nominating Committee	2024-05-21
Compensation Committee Chair	2022-06-05
Audit Committee	2023-11-12
Compensation Committee	2024-05-21

Garret Hampton

60 year

Governance Committee	2020-09-14
Nominating Committee	2020-09-14
Audit Committee	2025-11-19
Compensation Committee	2025-11-19

Jeffrey Elliott

48 year

Governance Committee	2024-10-01
Nominating Committee	2024-10-01
Audit Committee	2025-03-19

Ivana Magovcevic-Liebisch

57 year

Audit Committee
Compensation Committee	2024-10-01

Myla Lai-Goldman

68 year

Audit Committee

Alan Sachs

Compensation Committee

2025-11-19

Scott Mendel

59 year

Audit Committee

2023-05-14

Latest Appointments: Quanterix Corporation

Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Names Everett Cunningham President and CEO	MT
Jan. 08	Quanterix Corporation Announces Chief Executive Officer Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix Corporation Announces Management Changes, Effective January 19, 2026	CI
Jan. 08	Quanterix appoints Everett Cunningham as president and CEO effective January 19, 2026	RE
Nov. 20	Quanterix Corporation Announces Board Changes	CI
25-07-15	Kent Lake Issues a Letter to Quanterix Corporation	CI

More news

Former Officers and Directors: Quanterix Corporation

Insider

Positions held

SinceUntil

Masoud Toloue

Director/Board Member	2022-04-24	2026-01-18
Chief Executive Officer	2022-04-24	2026-01-18
Corporate Officer/Principal	2021-06-08	2022-04-24
President	2022-04-24	2026-01-18

Paul Meister

Director/Board Member	2013-08-14	2025-11-19
Independent Dir/Board Member	2013-08-14	2025-11-19

David Walt

Director/Board Member	2007-03-31	2025-11-19
Founder	2007-03-31	2025-11-19
Independent Dir/Board Member	2007-03-31	2025-11-19

Sarah Hlavinka McConnell

Director/Board Member	2019-07-24	2025-07-07
Independent Dir/Board Member	2019-07-24	2025-07-07

Martin Madaus

Director/Board Member	2025-03-23	2025-07-07
Chief Executive Officer	2011-09-30	2012-06-30
Chairman	2022-08-07	2025-03-23
Independent Dir/Board Member	2014-05-31	2022-08-07
President	2011-05-31	2012-06-30

Laurie Olson

Director/Board Member	2021-04-26	2024-06-02
Independent Dir/Board Member	2021-04-26	2024-06-02

Daniel Pikora

Chief Operating Officer	2022-09-05	2024-05-20
Corporate Officer/Principal	2022-04-30	2022-09-05

Brian Blaser

Director/Board Member	2023-01-05	2024-05-02
Independent Dir/Board Member	2023-01-05	2024-05-02

David C. Duffy

Chief Tech/Sci/R&D Officer

2011-10-17

2024-04-30

Michael Doyle

Director of Finance/CFO	2021-07-11	2024-03-30
Corporate Officer/Principal	2021-07-11	2024-03-30
Treasurer	2021-07-11	2024-03-30

Keith Crandell

Director/Board Member	2007-05-31	2023-06-06
Independent Dir/Board Member	2007-05-31	2023-06-06

Samira Amini

Human Resources Officer

2021-09-30

2023-05-31

Laurie A. Churchill

General Counsel	2023-01-31	-
Corporate Secretary	-	-

Gerrit Smith

Chief Operating Officer	2020-12-31	-
Corporate Officer/Principal	-	2022-09-30

Shawn Stetson

Comptroller/Controller/Auditor	2019-05-31	2022-08-31
Director of Finance/CFO	2021-05-10	2021-07-11
Treasurer	2021-05-10	2021-07-11

John Fry

General Counsel	2018-12-31	2022-08-11
Corporate Secretary	2018-12-31	2022-08-11

E. Hrusovsky

Chief Executive Officer	2015-03-03	2022-04-24
Chairman	2014-06-09	2022-08-07
President	2015-03-03	-

Dawn R. Mattoon

Chief Tech/Sci/R&D Officer	2018-01-31	-
Corporate Officer/Principal	2018-01-31	-

Denise Chittick

Human Resources Officer

2020-12-31

2022-06-30

Richard Haigh

Chief Tech/Sci/R&D Officer

2020-12-31

2022-04-30

Bruce J. Bal

Chief Operating Officer	2016-04-30	2020-11-15
Corporate Officer/Principal	2020-11-15	2022-03-31

Marijn Dekkers

Director/Board Member	2017-03-30	2021-12-30
Independent Dir/Board Member	2017-03-30	2021-12-30

William Geist

Chief Operating Officer

2020-11-15

2021-11-11

Richard Andy Keys

Corporate Officer/Principal	2021-02-28	2021-09-30
Sales & Marketing	2019-04-30	2021-02-28

Amol Chaubal

Director of Finance/CFO

2019-04-11

2021-05-10

Paulo Carvalho

Corporate Officer/Principal

2021-04-30

Darrin Crisitello

Corporate Officer/Principal

2020-12-31

John Connolly

Director/Board Member	2012-11-30	2020-08-13
Independent Dir/Board Member	2012-11-30	2020-08-13

Amee Desjourdy

Human Resources Officer

2019-07-31

2019-12-31

Jackson Streeter

Corporate Officer/Principal

2018-10-31

2019-08-31

David H. Wilson

Corporate Officer/Principal

2011-10-16

2019-07-31

Douglas Cole

Director/Board Member	2007-05-31	2019-07-24
Independent Dir/Board Member	2007-05-31	2019-07-24

Ernest Orticerio

Chief Operating Officer	2011-12-31	-
Director of Finance/CFO	2011-12-31	2017-02-28
Corporate Officer/Principal	2017-03-31	2019-04-30

Joseph Driscoll

Director of Finance/CFO

2017-03-31

2019-04-11

Dennis Sandstedt

Director/Board Member

2012-11-13

2017-11-05

Julien Bradley

Corporate Officer/Principal	2012-02-29	2012-07-22
Sales & Marketing	2012-07-22	2016-05-31

Elisabeth Colunio

Human Resources Officer

2015-12-31

Paul Chapman

Director/Board Member	2012-07-19	2015-03-03
Chief Executive Officer	2012-07-19	2015-03-03
President	2012-07-19	2015-03-03

James Drummey

Corporate Officer/Principal

2011-12-31

David Okrongly

Chief Executive Officer	2009-07-31	2011-04-30
President	2010-01-21	2011-04-30

David Hanlon

Investor Relations Contact	-	-
Sales & Marketing	2007-12-31	-

David R. Fournier

Chief Tech/Sci/R&D Officer

2011-06-02

Nicholas Naclerio

Chief Executive Officer	2007-03-31	2009-07-31
Chairman	2007-03-31	-
Founder	2007-03-31	-

Amy Achorn

Investor Relations Contact

James Nahirny

Director/Board Member

Ed Joyce

Investor Relations Contact

Philip Gardella

Director of Finance/CFO

Maya Nimnicht

Public Communications Contact

Stephen Hrusovsky

Investor Relations Contact

Age distribution of managers

Parity Men Women

Male	13
Female	4

Of which Executive Committee

Male	6
Female	3

Of which Directors

Male	7
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Employees

450

Sector

Advanced Medical Equipment & Technology

More about the company